Pomalidomide-C6-O-C5-O-C4-COOH

• CAT Number: I042620
• CAS Number: 2375774-54-0
• Molecular Formula: C29H41N3O8
• Molecular Weight: 559.65
• Purity: ≥95%
• Synonyms: 5-[5-[6-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]hexoxy]pentoxy]pentanoic acid
• InChI: InChI=1S/C29H41N3O8/c33-24-15-14-23(27(36)31-24)32-28(37)21-11-10-12-22(26(21)29(32)38)30-16-5-1-2-6-17-39-18-7-3-8-19-40-20-9-4-13-25(34)35/h10-12,23,30H,1-9,13-20H2,(H,34,35)(H,31,33,36)
• InChIKey: STEWOGZNWZMCIJ-UHFFFAOYSA-N
• SMILES: C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)NCCCCCCOCCCCCOCCCCC(=O)O

Pomalidomide-C6-O-C5-O-C4-COOH（Cat No.:I042620）is a modified form of pomalidomide, an immunomodulatory drug commonly used in the treatment of multiple myeloma. The structure includes a chemical linker, consisting of a series of functional groups (C6-O-C5-O-C4-COOH), which is designed to enhance the drug’s properties, such as its solubility, pharmacokinetics, or targeting capabilities. This modification aims to optimize pomalidomide’s effectiveness in treating cancers by potentially improving its ability to interact with specific targets or extend its therapeutic duration. It is undergoing investigation in research to assess its efficacy and safety in advanced cancer therapies.